Tevogen Other Stockholder Equity from 2010 to 2024

TVGNW Stock   0.05  0  5.63%   
Tevogen Bio Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity will likely drop to 0.86 in 2024. During the period from 2010 to 2024, Tevogen Bio Other Stockholder Equity regression line of quarterly data had mean square error of 32.9 B and geometric mean of  40,461. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
0.9
Current Value
0.86
Quarterly Volatility
242.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.5 K, Interest Expense of 227.9 K or Selling General Administrative of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
  
Check out the analysis of Tevogen Bio Correlation against competitors.

Latest Tevogen Bio's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Tevogen Bio Holdings over the last few years. It is Tevogen Bio's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Tevogen Other Stockholder Equity Regression Statistics

Arithmetic Mean468,983
Geometric Mean40,461
Coefficient Of Variation51.75
Mean Deviation187,593
Median586,228
Standard Deviation242,721
Sample Variance58.9B
Range586.2K
R-Value(0.69)
Mean Square Error32.9B
R-Squared0.48
Significance0
Slope(37,686)
Total Sum of Squares824.8B

Tevogen Other Stockholder Equity History

2024 0.86
2023 0.9
2022 1.0

About Tevogen Bio Financial Statements

Tevogen Bio investors use historical fundamental indicators, such as Tevogen Bio's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tevogen Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity 0.90  0.86 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tevogen Stock Analysis

When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.